Immunization, Hib3 in Slovakia
Slovakia: Immunization, Hib3 was 96.0% in 2024. ▲ Rising
Immunization, Hib3 in Slovakia, 1996–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Slovakia is 96.0%, measured in 2024.
Compared with earlier readings it is down 1.0% over ten years.
Over the whole period, immunization, hib3 in Slovakia peaked at 99.0% in 2003 and was at its lowest, 3.0%, in 1996.
Slovakia ranks 46th of 191 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 29 years of available data.
Immunization, Hib3 in Slovakia, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1996 | 3.0% | — |
| 1997 | 30.0% | +900.0% |
| 1998 | 36.0% | +20.0% |
| 1999 | 47.0% | +30.6% |
| 2000 | 59.0% | +25.5% |
| 2001 | 70.0% | +18.6% |
| 2002 | 92.0% | +31.4% |
| 2003 | 99.0% | +7.6% |
| 2004 | 99.0% | +0.0% |
| 2005 | 99.0% | +0.0% |
| 2006 | 99.0% | +0.0% |
| 2007 | 99.0% | +0.0% |
| 2008 | 99.0% | +0.0% |
| 2009 | 99.0% | +0.0% |
| 2010 | 99.0% | +0.0% |
| 2011 | 99.0% | +0.0% |
| 2012 | 99.0% | +0.0% |
| 2013 | 98.0% | -1.0% |
| 2014 | 97.0% | -1.0% |
| 2015 | 96.0% | -1.0% |
| 2016 | 96.0% | +0.0% |
| 2017 | 96.0% | +0.0% |
| 2018 | 97.0% | +1.0% |
| 2019 | 97.0% | +0.0% |
| 2020 | 97.0% | +0.0% |
| 2021 | 97.0% | +0.0% |
| 2022 | 97.0% | +0.0% |
| 2023 | 96.0% | -1.0% |
| 2024 | 96.0% | +0.0% |
Slovakia compared with similar countries
- Slovakia's 96.0% is above the median for high income countries, which is 95.0%, 1.0× the median. (62 countries reporting)
- Slovakia's 96.0% is above the median for Europe & Central Asia, which is 94.0%, 1.0× the median. (50 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 29.0% | 3.0% | 47.0% | 4 |
| 2000s | 91.4% | 59.0% | 99.0% | 10 |
| 2010s | 97.4% | 96.0% | 99.0% | 10 |
| 2020s | 96.6% | 96.0% | 97.0% | 5 |
Countries ranked near Slovakia
More health data for Slovakia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9332 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,433 deaths per 1,000 people (2090)
- Number of infants who die before age 1 28 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.48 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0234 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.33 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Slovakia?
- Immunization, hib3 in Slovakia was 96.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Slovakia?
- The highest recorded value was 99.0% in 2003.
- What is the lowest immunization, hib3 recorded in Slovakia?
- The lowest recorded value was 3.0% in 1996.
- How does Slovakia rank for immunization, hib3?
- Slovakia ranks 46th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Slovakia?
- Over the last ten years it is down 1.0%. The long-run trend across the full record is rising.
- Where does this Slovakia data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 29 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.